Aprea Therapeutics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Sale
5AM VENTURES IV, L.P. other: Former 10% holder
Common Stock 255,000 N/A N/A
Sale
ROCKLAGE SCOTT M other: Former 10% holder
Common Stock 255,000 N/A N/A
Sale
KDEV INVESTMENTS AB 10 percent owner
Common Stock 210,548 N/A N/A
Purchase
HEALTHCAP VII, L.P. 10 percent owner
Common Stock 266,667 $15 $4,000,005
Purchase
VERSANT VANTAGE I, L.P. 10 percent owner
Common Stock 333,333 $15 $4,999,995
Option
SEIZINGER BERND R. director
Stock Option (right to buy) 263,970 $0.07 $18,478
Option
SEIZINGER BERND R. director
Common Stock 263,970 $0.07 $18,478
Purchase
CHRISTENSON JOHAN director
Common Stock 266,667 $15 $4,000,005
Purchase
VERSANT V LUXCO S.A R.L. 10 percent owner
Common Stock 333,333 $15 $4,999,995
Purchase
REDMILE GROUP, LLC 10 percent owner
Common Stock 400,000 $15 $6,000,000
Purchase
5AM VENTURES IV, L.P. other: Former 10% holder
Common Stock 333,333 $15 $4,999,995
Purchase
KORBEL GREGORY ALAN officer: VP of Business Dev't
Common Stock 500 $15 $7,500
Purchase
ATTAR EYAL C. officer: SVP, Chief Medical Off..
Common Stock 200 $15 $3,000
Purchase
COIANTE SCOTT M officer: SVP, Chief Financial O..
Common Stock 2,500 $15 $37,500
Purchase
SCHADE CHRISTIAN S director, officer: President & ..
Common Stock 6,000 $15 $90,000
Purchase
HENNEMAN JOHN B III director
Common Stock 5,000 $15 $75,000
Purchase
MAGNI GUIDO director
Common Stock 6,500 $15 $97,500

Showing 50 to 67 of 67 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.